ARCHIVES

FDA Approves Cyramza for Stomach Cancer; Zykadia in NSCLC; Lipiodol for HCC Imaging; And Cobas HPV Test for Primary Screening

This article is from The Cancer Letter archive.

Vol. 37 No. 4 | April 25, 2014

Download PDF Visit The Full Archive

Related Articles

Phase III Trial In Recurrent Disease Shows Lower Risk of Progression or Death by 34%

June 28, 2013

Tacoma Tests Of Two Patients Who Received Bahamas Treatment Are Positive For AIDS; Sera Contaminated

July 12, 1985

FDA Approves Xtandi For Late-Stage Castration-Resistant Prostate Cancer

August 31, 2012

Cancer Planners Revise Some Project Areas, Drop Some, Add New Ones

February 8, 1974

Rosenberg Team May Have Cloned Melanoma Gene

May 31, 1991

FDA Grants Accelerated Approval To Ferriprox for Iron Overload

October 28, 2011